This blog is not affiliated or endorsed, by Nassau OTB, a public benefit corporation, subject to the New York Freedom
of Information Law, NY Pub Off Law Sec 84 et seq.
Wednesday, March 8, 2023
Leave new york
Pediatric Clinical Trial Update from the
Faustman Lab
March 8, 2023
Dear Friends,
We wanted to update you that the Faustman Lab at MGH is still recruiting for our first pediatric BCG clinical trial. This trial is for children 12-17 years old.
If you are interested in your child participating, please consult the full inclusion and exclusion criteria for this study that can be found at clinicaltrials.gov (NCT05180591). The requirements for participation include but are not limited to an average HbA1c over the past three months between 7.00 and 9.00%, birth in the United States, willingness to be on a CGM for the duration of the trial, and no prior BCG vaccination.
To learn more about the trial click here. Please take your time to review the eligibility criteria with your child. If you decide your child would like to participate and may be eligible for the study, please call (617-726-4084) or email (diabetestrial@partners.org) the lab to discuss scheduling a prescreening visit.
This is a huge step in our journey to reverse type 1 diabetes. As we continue to raise money for this non-profit program, additional pediatric study groups will gradually be added. Please spread the word directly and on social media using @faustmanlab and #BCG4T1D.
Sincerely,
Denise Faustman, MD, Ph.D.
If you would like to donate to the Faustman lab, please go to Faustmanlab.org and click on donate tab.
If you would like to donate by check, please send it to: Denise Faustman, MD, PhD
C/o Diabetes Trial
149 13th Street, CNY-3601
Charlestown, MA. 02129
Please write on memo line: For Dr. Faustman's research
No comments:
Post a Comment